Inter-individual variation in CYP2A6 activity and chronic obstructive pulmonary disease in smokers: Perspectives for an early predictive marker

Biochim Biophys Acta Mol Basis Dis. 2021 Jan 1;1867(1):165990. doi: 10.1016/j.bbadis.2020.165990. Epub 2020 Oct 19.

¹ Cardiovascular Respiratory Science Department, Sant'Andrea Hospital, Rome, Italy.
² Laboratory of Clinical Biochemistry, Sant'Andrea Hospital, Rome, Italy.
³ Clinical and Molecular Medicine Department, Sapienza University, Rome, Italy.
⁴ Laboratory of Clinical Biochemistry, Sant'Andrea Hospital, Rome, Italy; Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Rome, Italy.
⁵ Laboratory of Clinical Biochemistry, Sant'Andrea Hospital, Rome, Italy; Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University, Rome, Italy. Electronic address: marina.borro@uniroma1.it.

No abstract available

Keywords: COPD; CYP2A6; Chronic obstructive pulmonary disease; Nicotine metabolite ratio.

Publication types